Priming and expression of immune responses in the gastric mucosa

Microbes and Infection

Volumn 5, Issue 8, 2003, Pages 731-739

  Svennerholm, Ann Mari ^a   Quiding Järbrink, Marianne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Gastric immunity; Helicobacter pylori; Inflammation; Lymphocyte homing; Mucosal vaccines

Indexed keywords

CHEMOKINE; CHOLERA VACCINE; HELICOBACTER PYLORI VACCINE; RANTES; TYPHOID VACCINE;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; B LYMPHOCYTE ACTIVATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; CLINICAL FEATURE; DUODENUM; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE HOMING; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STOMACH MUCOSA;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 0037903206     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00113-8     Document Type: Review

References (42)

1. McColl K. Helicobacter pylori infection and its role in human disease-an overview. Pharm. World Sci. 18:1996;49-55.
2. Hamlet A., Thoreson A.-C., Nilsson O., Svennerholm A.-M., Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 116:1999;259-268.
3. Covacci A., Falkow S., Berg D.E., Rappuoli R. Did the inheritance of a pathogenicity island motif modify the virulence of Helicobacter pylori? Trends Microbiol. 5:1997;205-208.
4. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni J.F. Jr., Rabkin C.S. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature. 412:2001;99.
5. Mitchell H.M. The epidemiology of Helicobacter pylori. Curr. Top. Microbiol. Immunol. 241:1999;11-30.
6. Xia H.X., Talley N.J., Keane C.T., O'Morain C.A. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig. Dis. Sci. 42:1997;1821-1834.
7. Unge P. Antibiotic treatment of Helicobacter pylori infection. Curr. Top. Microbiol. Immunol. 241:1999;261-300.
8. Mattsson A., Lönroth H., Quiding-Järbrink M., Svennerholm A.-M. Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J. Clin. Invest. 102:1998;51-56.
9. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7:1987;265-276.
10. Haneberg B., Kendall D., Amerongen H.M., Apter F.M., Kraehenbuhl J.P., Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:1994;15-23.
11. Eriksson K., Quiding-Järbrink M., Osek J., Möller Å., Björk S., Kieny M.-P., Holmgren J., Czerkinsky C. Anatomical segmentation of the intestinal immune response in non-human primates: oral and rectal immunization induce differential homing of B cells to sites defined by their source of vascularisation. Infect. Immun. 67:1999;6210-6212.
12. 7): a functional role in Peyer's patch-specific lymphocyte homing. Proc. Natl. Acad. Sci. USA. 89:1992;8254-8258.
13. Zabel B.A., Agace W.W., Campbell J.J., Heath H.M., Parent D., Roberts A.I., Ebert E.C., Kassam N., Qin S., Zovko M., LaRosa G.J., Yang L.-L., Soler D., Butcher E.C., Ponath P.D., Parker C.M., Andrew D.P. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosa lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J. Exp. M. 190:1999;1241-1255.
14. Bowman E.P., Kuklin N.A., Youngman K.R., Lazarus N.H., Kunkel E.J., Pan J., Greenberg H.B., Butcher E.C. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J. Exp. M. 195:2002;269-275.
15. Quiding-Järbrink M., Nordström I., Granströn G., Butcher E.C., Lazarovits A.I., Kilander A., Jertborn M., Holmgren J., Czerkinsky C. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunization. A molecular basis for the compartmentalization of effector B cell responses. J. Clin. Invest. 99:1997;1281-1286.
16. Rosé J.R., Williams M.B., Rott L.S., Butcher E.C., Greenberg H.B. Expression of the mucosal homing receptor α4β7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J. Virol. 72:1998;726-730.
17. Lundin B.S., Johansson C., Svennerholm A.-M. Oral immunisation with a Salmonella enterica Serovar Typhi vaccine induces specific circulating mucosa-homing CD4+ and CD8+ T cells in humans. Infect. Immun. 70:2002;5622-5627.
18. Quiding-Järbrink M., Ahlstedt I., Lindholm C., Johansson E.-L., Lönroth H. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa. Gut. 49:2001;519-525.
19. high regulatory T-cells suppress the memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71:2003;1755-1762.
20. Svennerholm A.-M. Prospects for a mucosally-administered vaccine against Helicobacter pylori. Vaccine. 21:2003;347-353.
21. Sutton P., Wilson J., Lee A. Further development of the H. pylori mouse vaccination model. Vaccine. 18:2000;2677-2685.
22. Garhart C.A., Redline R.W., Nedrud J.G., Czinn S.J. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect. Immun. 70:2002;3529-3538.
23. Raghavan S., Svennerholm A.-M., Holmgren J. Effects of oral vaccination and immunomodulation by cholera toxin on experimental H. pylori infection, reinfection, and gastritis. Infect. Immun. 70:2002;4621-4627.
24. Mattsson A., Quiding-Järbrink M., Lönroth H., Hamlet A., Ahlstedt I., Svennerholm A.-M. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori infected subjects. Infect. Immun. 66:1998;2705-2712.
25. Quiding-Järbrink M., Lundin B.S., Lönroth H., Svennerholm A.-M. CD4+ and CD8+ T cell responses in Helicobacter pylori infected individuals. Clin. Exp. Immunol. 123:2001;81-87.
26. Fan X.J., Chua A., Shahi C.N., McDevitt J., Keeling P.W., Kelleher D. Gastric T lymphocyte responses to Helicobacter pylori in patients with H. pylori colonisation. Gut. 35:1994;1379-1384.
27. Strömberg E., Lundgren A., Edebo A., Lundin S., Svennerholm A.-M., Lindholm C. Increased frequency of activated T cells in the Helicobacter pylori-infected antrum and duodenum. FEMS Immunol. Med. Microbiol. 36:2003;159-168.
28. Strömberg E., Edebo A., Svennerholm A.-M., Lindholm C. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin. Diagn. Lab. Immunol. 10:2003;116-124.
29. D'Elios M.M., Manghetti M., Almerigogna F., Amedei A., Costa F. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 27:1997;1751-1755.
30. Lindholm C., Quiding-Järbrink M., Lönroth H., Hamlet A., Svennerholm A.-M. Local cytokine response in Helicobacter pylori infected subjects. Infect. Immun. 66:1998;5964-5971.
31. high regulatory cells in human peripheral blood. J. Immunol. 167:2001;1245-1253.
32. Mattsson A., Tinnert A., Hamlet A., Lönroth H., Bölin I., Svennerholm A.-M. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori infected subjects. Clin. Diagn. Lab. Immunol. 5:1998;288-293.
33. Karttunen R., Andersson G., Poikonen K., Kosunen T.U., Karttunen T., Juutinen K., Niemela S. Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin. Exp. Immunol. 82:1990;485-488.
34. Quiding-Järbrink M., Lönroth H., Ahlstedt I., Holmgren J., Svennerholm A.-M. Human gastric B cell responses can be induced by intestinal immunisation. Gut. 49:2001;512-518.
35. Salerno-Goncalves R., Pasetti M.F., Sztein M.B. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 169:2002;2196-2203.
36. Kilhamn J., Brevinge H., Quiding-Järbrink M., Svennerholm A.-M., Jertborn M. Induction and homing of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouch of colectomized patients. Infect. Immun. 69:2001;3466-3471.
37. Michetti M., Kelly C.P., Kraehenbuhl J.-P., et al. Gastric mucosal α4β7-integrin-positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice. Gastroenterology. 119:2000;109-118.
38. Dogan A., Du M., Koulis A., Briskin M.J., Isaacson P.G. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am. J. Pathol. 151:1997;1361-1369.
39. Shimoyama T., Everett S.M., Dixon M.F., Axon A.T., Crabtree J.E. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J. Clin. Pathol. 51:1998;765-770.
40. Hauser A.E., Debes G.F., Arce S., Cassese G., Hamann A., Radbruch A., Manz R.A. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J. Immunol. 169:2002;1277-1282.
41. Michetti P., Kreiss C., Kotloff K.L., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 116:1999;804-812.
42. Kotloff K.L., Sztein M.B., Wasserman S.S., Losonsky G.A., DiLorenzo S.C., Walker R.I. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect. Immun. 69:(6):2001;3581-3590.